Filing Flows › Verastem (VSTM) › Q2 2026
Verastem (VSTM) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 6, 2026
Verastem (VSTM) reported revenue of $40.1M for the second quarter 2026 (Q2 2026), up 19-fold from a year earlier and +115% from the quarter before. Operating margin was -81.6%, net loss $34.7M (86.5% of revenue).
Verastem, Q2 2026: revenue $40.1M (19× year over year), operating margin -81.6%, net loss $34.7M, operating cash flow −$43.9M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $40.1M | +115% | 19× |
| Operating profit | −$32.7M | — | — |
| Net earnings | −$34.7M | — | — |
| Operating cash flow | −$43.9M | — | — |
What changed
Revenue was $40.1M in Q2 2026, up 1775% year over year and up 115% from the previous quarter. Product revenue, net was the largest line at 63% of revenue. Product revenue, net added $22.9M year over year (up 1074%), 60% of the total change.
Operating costs exceeded revenue by $32.7M, an operating margin of -81.6%. Total costs grew 59% against revenue growth of 1775%. The fastest-growing cost line was Other operating costs (+806%). The quarter ended with a net loss of $34.7M, narrower than the previous quarter's $36.6M loss.
Operating cash flow was −$43.9M. Non-cash charges added back $3.4M of share-based compensation. Working capital and other items used $12.7M.
Questions
What was Verastem's revenue in the second quarter 2026?
Verastem (VSTM) reported revenue of $40.1M for the second quarter 2026 (Q2 2026), up 19-fold from a year earlier and +115% from the quarter before.
Was Verastem profitable in the second quarter 2026?
Operating loss was $32.7M (-81.6% of revenue) and net loss $34.7M.
Source: Verastem 10-Q on SEC EDGAR.